ETF Hearsay: New Psychedelics ETF filed

New Psychedelics ETF filed

PSYK ETF
Ticker: PSYK
Exchange: NYSE Arca
Expense ratio: TBD

Summary

Tracks an index of 25 companies listed in the USA or Canada involved in development of pyschedelics for medical use. Uses natural language algorithm to comb through public documents to identify companies in pyschedelics.

Original filing date: May 14, 2021
Effective date: July 28, 2021
Listing Date: TBD
CUSIP: TBD

Active: No
Index / Benchmark: Enhanced Consciousness Index

Investment Objective:
Seeks to track the performance, before fees and expenses, of the Enhanced Consciousness Index

Investment Strategy / Index Methodology:

Universe: Stocks listed in USA or Canada

Companies involved in development of psychedelics are identified and ranked using Solactive index calculation agent's natural language algorithm ARTIS. ARTIS reviews publicly available documents to identify these companies. Solactive reviews the list of companies identified by ARTIS and removes those that were wrongly identified.

Top 25 companies are selected and weighted by market capitalization, with constraints. If less than 25 companies are available, medical cannabis companies are added until 25 names are reached.

Constituents: 25

Adviser: Exchange Traded Concepts, LLC
Sub-Adviser: N/A
Portfolio Managers: Andrew Serowik and Travis Trampe
Administrator: U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services
Fund accountant: U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services
Transfer agent: U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services
Custodian: U.S. Bank National Association
Distributor: Quasar Distributors, LLC
Legal counsel: Morgan, Lewis & Bockius LLP
External accounting: TBD
Compliance: TBD

Prospectus is here.